Table 4.

Patient demographics and number of abdominal attacks in patients treated with 30 mg subcutaneous ecallantide ¹

	Patients (N = 149)
Patient demographics
Number of attacks	521
Age, mean (range)	34.4 (10–77)
Gender, %
Female	70.5
Male	29.5
Race/Ethnicity, %
Caucasian	88.6
Black	4.7
Hispanic	4.7
Other	2.0
Number of abdominal attacks per patient
Mean (SD)	3.5 (4.0)
Range	1-28
Total Attacks, n (%)
1 attack	57 (38)
2 attacks	29 (19)
3 attacks	24 (16)
4 attacks	8 (5)
5 attacks	6 (4)
>5 attacks	25 (17)

¹All patients treated with 30 mg subcutaneous ecallantide in EDEMA2, EDEMA3, EDEMA4 and DX-88/19 with any abdominal symptoms.